J. Petersen

Eosinophils altered phenotypically and primed by culture with granulocyte/macrophage colony-stimulating factor and 3T3 fibroblasts generate leukotriene C4 in response to FMLP.

W. Owen, K. Austen, J. Petersen, 1991, The Journal of clinical investigation.

IL-5-dependent conversion of normodense human eosinophils to the hypodense phenotype uses 3T3 fibroblasts for enhanced viability, accelerated hypodensity, and sustained antibody-dependent cytotoxicity.

W. Owen, K. Austen, M. Rothenberg, 1989, Journal of immunology.

Hypodense eosinophils and interleukin 5 activity in the blood of patients with the eosinophilia-myalgia syndrome.

R. Folkerth, A. Sheffer, R. Anderson, 1990, Proceedings of the National Academy of Sciences of the United States of America.

Interleukin 5 and phenotypically altered eosinophils in the blood of patients with the idiopathic hypereosinophilic syndrome

A. Sheffer, W. Owen, K. Austen, 1989, The Journal of experimental medicine.

Myeloid checkpoint blockade improves killing of T-acute lymphoblastic leukemia cells by an IgA2 variant of daratumumab

R. Burger, M. Peipp, J. Leusen, 2022, Frontiers in Immunology.

Inhibition of Polyclonally Induced Immunoglobulin Secretion by Aurothiomalate

J. Petersen, J. Petersen, 1984, Allergy.

Inhibition of T cell‐dependent antibody production by D‐penicillamine

J. Petersen, 1987, Allergy.

Autoreactive lymphocytes in thyroid disorders. II. Comparison of anti-thyroglobulin antibody production by plaque-forming cell, radio-immunological and enzyme-linked immunosorbent assays.

S. Husby, U. Feldt-Rasmussen, K. Siersbaek-Nielsen, 2009, Acta pathologica, microbiologica, et immunologica Scandinavica. Section C, Immunology.

Urinary secretory immunoglobulin A and free secretory component in pyelonephritis.

R. Goldblum, D. Neal, J. Petersen, 1995, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Blockade of CD47-Sirpα Interactions Improved Myeloid Effector Cell Mediated Lymphoma Cell Killing By the HLA-DR Antibody Apolizumab

M. Peipp, G. Weiner, A. Humpe, 2019, Blood.